Kolexia
Deiva Kumaran Pédiatrie
Deiva Kumaran
Pédiatrie
Hôpital Bicêtre
Le Kremlin-Bicêtre, France
222 Activités
192 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sclérose en plaques Sclérose Encéphalite Neuromyélite optique Sclérose en plaques récurrente-rémittente Névrite optique Maladies démyélinisantes Névrite Encéphalite à anticorps anti-récepteur N-méthyl-D-aspartate

Collaborateurs

Voir plus
Tardieu Marc
Tardieu Marc
Hôpital Bicêtre, Le Kremlin-Bicêtre, France
Maurey Helene
Maurey Helene
Hôpital Bicêtre, Le Kremlin-Bicêtre, France
Marignier Romain
Marignier Romain
Hôpital Pierre Wertheimer, Bron, France
Husson Beatrice
Husson Beatrice
Hôpital Bicêtre, Le Kremlin-Bicêtre, France

Industries

Voir plus
Novartis
18 collaboration(s)
Dernière en 2023
Sanofi
16 collaboration(s)
Dernière en 2022
Alexion
10 collaboration(s)
Dernière en 2022
Biogen
9 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis: A 2 Year, Double-blind, Randomized, Multicenter, Active-controlled Core Phase to Evaluate Safety & Efficacy of Daily Fingolimod vs Weekly Interferon β-1a im in Pediatric Patients With Multiple Sclerosis and 5 Year Fingolimod Extension Phase
Essai Clinique (Novartis)   12 mars 2024
Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder: An Open-Label Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
Essai Clinique (Horizon Therapeutics Ireland DAC)   22 février 2024
REMYELIKIDS: Exploring Cortical Remyelination in Children With Multiple Sclerosis
Essai Clinique (Assistance publique – Hôpitaux de Paris)   19 janvier 2024
Quelques mots avec Pr. Kumaran Deiva
Youtube @ The Sumaira Foundation   16 janvier 2024
The Response Study: A French registry on pregnancy in women with MS and related disorders and their children up to 6 years-Protocol, recruitment status, and baseline characteristics.
Multiple sclerosis (Houndmills, Basingstoke, England)   11 janvier 2024
A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis: An Open-Label, Randomized, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 in Pediatric Subjects Aged 10 to Less Than 18 Years for the Treatment of Relapsing-Remitting Multiple Sclerosis, With Optional Open-Label Extension
Essai Clinique (Biogen)   09 janvier 2024
PASTA: High Dose Steroids in Children With Stroke and Unilateral Focal Arteriopathy: A Multicentre Randomized Controlled Trial PASTA (Paediatric Arteriopathy Steroid Aspirin) Trial
Essai Clinique (Insel Gruppe AG, University Hospital Bern)   08 janvier 2024
Control of disease activity with large extended-interval dosing of rituximab/ocrelizumab in highly active pediatric multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England)   02 janvier 2024
IDAR: Immediate Versus Delayed Treatment With Azathioprine or Rituximab in Anti-myelin Oligodendrocytes Glycoprotein (Anti-MOG) Antibodies Associated Acute Demyelinating Syndromes in Children: a Randomized Controlled Clinical Trial
Essai Clinique (Assistance publique – Hôpitaux de Paris)   22 novembre 2023
Les thérapies géniques en neurologie
Pratique Neurologique - FMC   30 octobre 2023